← Back to Search

Caregiver Coaching for Dementia (CuRB-IT Trial)

N/A
Recruiting
Led By Rita A Jablonski, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The care provided consists of help with at least 2 Instrumental Activities of Daily Living or one Activity of Daily Living
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily during weeks 49, 50, and 51
Awards & highlights

CuRB-IT Trial Summary

This trial will test an online intervention for caregivers of people with dementia. 35 caregivers will use the intervention for 3 weeks, then all 266 caregivers will be surveyed and use the intervention for 12 weeks.

Who is the study for?
This trial is for family caregivers over 18 years old who help a relative with mild cognitive impairment or dementia and face resistance when providing care. Caregivers must speak/read English, have internet access, and share living or cooking space with the care recipient.Check my eligibility
What is being tested?
The study tests CuRB-IT, an intervention for caregivers dealing with care-resistant behavior in dementia patients. Participants are split into two groups: one starts CuRB-IT immediately and the other after a delay, both completing surveys and diaries to track progress.See study design
What are the potential side effects?
Since this trial involves coaching rather than medication, there aren't typical drug side effects. However, participants may experience emotional distress or fatigue from discussing caregiving challenges.

CuRB-IT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need help with daily tasks like dressing or using the bathroom.

CuRB-IT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily during weeks 49, 50, and 51
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily during weeks 49, 50, and 51 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dementia
Change in caregiver self-efficacy coping skills
Change in caregiver self-efficacy measured by selection of items from 10-item CurB-CuRB-IT Strategy checklist
+1 more

CuRB-IT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate InterventionExperimental Treatment1 Intervention
Complete baseline survey, complete 3 weeks of daily diaries and intermittent survey, receive 12 weeks of CurB-IT, then complete 3 rounds of 21-day daily diaries and intermittent surveys while receiving attention during the 12-week intervals between daily diaries.
Group II: Delayed interventionActive Control1 Intervention
Complete baseline survey, complete 3 weeks of daily diaries, receive 12 weeks of attention, complete 3 weeks of daily diaries and 1 intermittent survey, receive 12 weeks of CurB-IT, then complete 2 rounds of 21-day daily diaries and intermittent surveys while receiving attention during the 12-week intervals between daily diaries.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,573 Previous Clinical Trials
2,273,011 Total Patients Enrolled
12 Trials studying Dementia
838 Patients Enrolled for Dementia
Rita A Jablonski, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

CuRB-IT Clinical Trial Eligibility Overview. Trial Name: NCT05098652 — N/A
Dementia Research Study Groups: Immediate Intervention, Delayed intervention
Dementia Clinical Trial 2023: CuRB-IT Highlights & Side Effects. Trial Name: NCT05098652 — N/A
CuRB-IT 2023 Treatment Timeline for Medical Study. Trial Name: NCT05098652 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility criteria for this clinical trial inclusive of individuals aged 35 or older?

"This trial is seeking individuals aged 18 or older and younger than 95 years."

Answered by AI

Is it feasible to partake in this investigation?

"266 individuals that meet the criteria of being aged between 18 and 95 with a diagnosis of dementia will be accepted into this clinical trial."

Answered by AI

Are there any available slots for participants in this research project?

"Clinicaltrials.gov shows that this clinical trial, which first appeared on February 1st 2023 and was last edited on September 16th 2022, is not currently seeking participants. Despite this fact, 394 other trials are presently recruiting new patients into their studies."

Answered by AI
~177 spots leftby Aug 2027